Score Overview
PeriodNet IncomeRevenueScoreGrowthTrendConsistencyGrowthTrendConsistency
5 Years
3.9
-75.42%
60%
—
-5.91%
40%
—
5 Years
Score3.9
Net Growth-75.42%
Net Trend60%
Net Income Consistency—
Rev Growth-5.91%
Rev Trend40%
Revenue Consistency—
Ironwood Pharmaceuticals Inc fundamental performance
Between 2015 and 2025, revenue grew from $ 149M to $ 296M and net income went from -$ 142M to $ 24M. Revenue increased in 6 of those 10 years; net income in 6.
Across Ironwood Pharmaceuticals Inc's full reported history, from 2010 to 2025, revenue grew from $ 43M to $ 296M and net income went from -$ 52M to $ 24M. Revenue increased in 69% of the years measured; net income in 56%.
Ironwood Pharmaceuticals Inc currently holds a 5-year HDB Score of 3.9 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 4.32 | — |
1 Year2025-08-12 | $ 0.98 | 339.69% |
5 Years2021-08-12 | $ 13.84 | -68.79% |
10 Years2016-08-12 | $ 11.18 | -61.37% |
All Time2010-02-03 | $ 9.75 | -55.70% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 | 10 Years2016-08-12 | All Time2010-02-03 |
|---|---|---|---|---|---|
| Price | $ 4.32 | $ 0.98 | $ 13.84 | $ 11.18 | $ 9.75 |
| Return | — | 339.69% | -68.79% | -61.37% | -55.70% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 389M | $ 129M | $ 79M |
| 2025 | $ 296M | $ 24M | $ 215M |
| 2024 | $ 351M | $ 880K | $ 88M |
| 2023 | $ 442M | -$ 1.00B | $ 92M |
| 2022 | $ 410M | $ 175M | $ 656M |
| 2021 | $ 413M | $ 528M | $ 620M |
| 2020 | $ 389M | $ 106M | $ 364M |
| 2019 | $ 428M | $ 21M | $ 177M |
| 2018 | $ 346M | -$ 282M | $ 173M |
| 2017 | $ 298M | -$ 116M | $ 221M |
| 2016 | $ 273M | -$ 81M | $ 305M |
| 2015 | $ 149M | -$ 142M | $ 439M |
| 2014 | $ 76M | -$ 189M | $ 248M |
| 2013 | $ 22M | -$ 272M | $ 197M |
| 2012 | $ 150M | -$ 72M | $ 168M |
| 2011 | $ 65M | -$ 64M | $ 164M |
| IPO2010 | $ 43M | -$ 52M | $ 248M |
Explore beyond IRWD
You're looking at Ironwood Pharmaceuticals Inc. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score — 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
